QuantiLight

Curated by Signal

In vitro diagnostic platform for therapeutic drug monitoring from home

Overview

In vitro diagnostic platform for therapeutic drug monitoring from home. The bioluminescent sensor technology enables patients with chronic diseases to conduct lab blood testing platform designed for at home monitoring of patients.

Key facts

Founded: 2022
Headquarters: Heidelberg, Germany
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Booking Health
Provider of medical tourism services
Health TechnologyBad Honningen, Germany
INDAMED
Provider of practice management software and services for healthcare providers
Health TechnologySchwerin, Germany
Appovo
Developer of fitness applications
Health TechnologyMarburg, Germany

About QuantiLight

What does QuantiLight do?

In vitro diagnostic platform for therapeutic drug monitoring from home.

Where is QuantiLight headquartered?

QuantiLight is headquartered in Heidelberg, Germany.

When was QuantiLight founded?

QuantiLight was founded in 2022.

Which sector is QuantiLight in?

QuantiLight operates in Health Technology.

Who are QuantiLight's competitors?

Companies similar to QuantiLight include Booking Health, INDAMED, and Appovo.